ATE327982T1 - Benzylmorpholinderivate - Google Patents

Benzylmorpholinderivate

Info

Publication number
ATE327982T1
ATE327982T1 AT03792992T AT03792992T ATE327982T1 AT E327982 T1 ATE327982 T1 AT E327982T1 AT 03792992 T AT03792992 T AT 03792992T AT 03792992 T AT03792992 T AT 03792992T AT E327982 T1 ATE327982 T1 AT E327982T1
Authority
AT
Austria
Prior art keywords
benzylmorpholine
derivatives
alkyl
phenyl
independently
Prior art date
Application number
AT03792992T
Other languages
English (en)
Inventor
Barry Peter Clark
Peter T Gallagher
Helen L Haughton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0219685A external-priority patent/GB0219685D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE327982T1 publication Critical patent/ATE327982T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
AT03792992T 2002-08-23 2003-08-18 Benzylmorpholinderivate ATE327982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219685A GB0219685D0 (en) 2002-08-23 2002-08-23 Benzyl morpholine derivatives
US41532702P 2002-10-01 2002-10-01

Publications (1)

Publication Number Publication Date
ATE327982T1 true ATE327982T1 (de) 2006-06-15

Family

ID=31948035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792992T ATE327982T1 (de) 2002-08-23 2003-08-18 Benzylmorpholinderivate

Country Status (7)

Country Link
US (1) US7294623B2 (de)
EP (1) EP1546123B1 (de)
AT (1) ATE327982T1 (de)
AU (1) AU2003261245A1 (de)
DE (1) DE60305717T2 (de)
ES (1) ES2264028T3 (de)
WO (1) WO2004018440A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219687D0 (en) * 2002-08-23 2002-10-02 Lilly Co Eli Benzyl morpholine derivatives
GB0319793D0 (en) 2003-08-22 2003-09-24 Lilly Co Eli Pyridinylmorpholine derivatives
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AU2005238296A1 (en) 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759013R (fr) 1969-11-17 1971-05-17 Ici Ltd Derives de la
GB1412546A (en) 1973-08-08 1975-11-05 Ici Ltd Morpholine derivatives
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
US4956388A (en) 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
JP2001517628A (ja) 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー 注意欠陥／多動障害の治療法
US6503905B1 (en) * 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
ES2246488T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC Reboxetina para tratar la migraña.
DE60324685D1 (de) 2002-08-23 2008-12-24 Lilly Co Eli 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren

Also Published As

Publication number Publication date
AU2003261245A1 (en) 2004-03-11
EP1546123A1 (de) 2005-06-29
WO2004018440A1 (en) 2004-03-04
DE60305717T2 (de) 2007-05-03
EP1546123B1 (de) 2006-05-31
ES2264028T3 (es) 2006-12-16
DE60305717D1 (de) 2006-07-06
US20060052377A1 (en) 2006-03-09
US7294623B2 (en) 2007-11-13

Similar Documents

Publication Publication Date Title
EP1642880A4 (de) Proteininhibitoren der hsp90-familie
NO20015447D0 (no) Kinolinderivater som inhibitorer av MEK enzymer
DE60317326D1 (de) Phenylalkansäure- und phenyloxyalkansäure-derivate als hppar aktivatore
WO2003055441A3 (en) Medicaments
NO943495L (no) Kondenserte cykliske forbindelser og deres anvendelse
DK1178967T3 (da) Quinolinderivater som inhibitorer af MEK-enzymer
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NO20015446L (no) Kinolin-derivater som inhibitorer for MEK-enzymer
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
ATE537158T1 (de) M-stage-kinesin-inhibitor
BG105417A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
WO2003035610A1 (en) Sulfonamide derivative having mmp inhibitory activity
MY113518A (en) Benzothiazolone derivatives
AU2001269540A1 (en) Serotonin reuptake inhibitors
ATE144530T1 (de) Glutathionderivat
CA2209422A1 (en) 4-amino-3-acylnaphthyridine derivatives
DE60305717D1 (de) Benzylmorpholinderivate
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
DE60213087D1 (de) Pyrimidin-derivate als selektive inhibitoren von cox-2
DK1628968T3 (da) 4-imidazolin-2-on-forbindelser
ES2190781T3 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties